Value of multislice spiral CT on the effect of conversion therapy for gastric cancer patients with positive exfoliative cytology
10.3760/cma.j.cn113855-20200110-0032
- VernacularTitle:多层螺旋CT对单纯脱落细胞学阳性胃癌患者转化治疗疗效的评估价值
- Author:
Yingjie HAO
1
;
Tao ZHENG
;
Yang LIU
;
Qun ZHAO
;
Yong LI
;
Bibo TAN
;
Liqiao FAN
;
Zhidong ZHANG
;
Dong WANG
;
Honghai GUO
;
Ping′an DING
;
Xiayu DU
Author Information
1. 河北医科大学第四医院外三科，石家庄 050011
- From:
Chinese Journal of General Surgery
2020;35(8):603-606
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the exfoliative value of multi-slice CT (MSCT) on conversion therapy of gastric cancer patients with positive evaluation cytology (P 0CY 1) . Methods:A total of 36 P 0CY 1 gastric cancer patients receiving conversion therapy in a prospective, single-center, phase Ⅱ clinical trial were enrolled. MSCT examinations were performed before and after conversion therapy. Its solid tumor efficacy evaluation criteria (response evaluation criteria in solid tumors, Recist) 1.1 score and tumor volume reduction rate were evaluated. The Spearman correlation test was used to analyze the correlation between Recist 1.1 score and tumor volume reduction rate and the results of conversion therapy. The ROC curve was used to determine the defined value of the volume reduction rate to identify the effectiveness of conversion therapy, and formulate new grading standards. Results:According to the conversion of free cancer cells in the abdominal cavity , 15 of 36 patients had successful conversion therapy and 21 had failed. The rate of tumor volume reduction in the successful and failed conversion groups was 44.38%±37.86% and -54.96%±156.92%, respectively( P=0.016). The Recist 1.1 score was moderate correlated with the results of conversion therapy ( R=0.540, P=0.001), and the rate of tumor volume reduction was significantly correlated with the results of conversion therapy ( R=0.657, P<0.001). When the tumor volume reduction rate of 26.27% was used as the effective threshold for evaluating conversion therapy, the AUC under the ROC curve was the largest, and the sensitivity and specificity were 80.0% and 85.7%, respectively. Conclusion:Both the MSCT-measured Recist 1.1 score and the tumor volume reduction rate can be used to evaluate the efficacy of conversion therapy in patients with pure exfoliated cytology-positive gastric cancer, and CT tumor volume measurement significantly correlates with conversion therapy results.
